Event ID # 88871
Date:
Monday, 7 December 2009
Tuesday, 8 December 2009
Wednesday, 9 December 2009
 Time:
09:00 - 17:00
09:00 - 17:00
09:00 - 17:00
Event:

World Influenza Congress Europe 2009
Host:

Terrapinn Ltd
Location:

(38, Boulevard de Waterloo)   Google Map
Hilton Hotel
38, Boulevard de Waterloo, Brussels, Belgium 1000
Contact:
Paul Gilbertson		 Phone:
+44 (0)20 7092 1245
Email:
paul.gilbertson@terrapinn.com
Website:
http://www.terrapinn.com/2009/flu/
Price:
2425
Full details:

Innovation and opportunity for pharma, biotechs, healthcare and investors 

World Influenza Congress Europe is the annual conference addressing every aspect of policy and planning, research & development, and stakeholder partnerships.  

The World’s largest influenza and antivirals vaccine congress addressing global pandemic trends and key regulatory and industry response to the global H1N1 
Major pandemic influenza A(H1N1) vaccine clinical progress and uptake including ongoing H5N1 pandemic and universal vaccine research, production and manufacture and antiviral application 

Over 45 sessions covering strategic pandemic influenza preparedness and response with unique industry showcases outlining critical progress in 
Regulatory response, industry preparation, H1N1 and H5N1 R&D, antiviral combinations, influenza production, vaccine immunogenicity, novel DNA technology and novel antigen delivery vehicles 

Unrivalled global participation from regulators, pharma and biotech with every key player in the influenza market participating Critical response from Baxter, Crucell, F. Hoffmann-La Roche, GSK Biologicals, Intercell, Novartis Vaccines & Diagnostics, sanofi pasteur, Solvay Biologicals and many more  

2009 key speakers include:  

* Dr Robin Robinson, Director, BARDA, ASPR, US Department of Health and Human Services 
* Dr Klaus Stöhr, Vice President, Global Head, Influenza Strategy Liaison, Novartis Vaccines and Diagnostics 
* Dr Hartmut Ehrlich, Vice President, Global Research and Development, Baxter BioScience 
* Dr Emmanuel Hanon, Vice President, Influenza Vaccine Franchise, GSK Biologicals 
* Dr Derek O'hagan, Vice President and Head of Vaccine Delivery Research, Novartis Vaccines & Diagnostics 
* Noel Barrett, Vice President, Research and Development, Baxter BioScience 
* Dr Nathalie Garçon, Vice President, Head of Research and North America R&D, GSK Biologicals 
* And many more! 

Please visit the website for full programme and speaker details. http://www.terrapinn.com/2009/flu/ 

Venue 

Hilton Brussels hotel - 38, Boulevard de Waterloo, Brussels, Belgium 1000
Tel: 32-2-504-1111 Fax: 32-2-504-2111